NodePositiveBilateralProphylacticMastectomyPhysicalactivity mayreduce therisk of breastcancersRADER+LumpectomyHormoneReplacementTherapyAdenocarcinomaAyurvedaPI3KinaseInhibitorsCytostaticAromataseInhibitorsNeoplasmImmunotherapyGeneticPredispositionMultifocalTumorsRelapseInvasiveBreastCancerTyrosine-KinaseInhibitorCAMMegestrolAcetateOvarianSuppressionAntiemeticPalpationApoptosisPathologicResponseMorpheaAnastrozoleSelf-examinationLumpHormoneReceptorStatusFamilyHistoryFibroadenomaTumorGradeAngiogenesisKappaEpsilonMastectomyTripleNegativeBreastCancerEstradiolGenomicTestingCMFChemotherapy1 in 8womenBreastTomosynthesisLymphoscintigraphyMultimodalityTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCystLCISMethotrexatePaclitaxelCDK4/6InhibitorsIn-situCarcinomaBRCAGene5-FluorouracilCalcificationsNodeNegativeStagingDefinitiveSurgeryDimplingExcisionalBiopsyBrachytherapyFlowCytometryDown-StagingDoseDenseTherapyCytotoxicNeoadjuvantTherapyProgestinDocetaxelCachexiaHER-2ER-LymphNodeStatusGeneticCounselingAdjuvantTherapyMastodyniaTamoxifenAlopeciaRaloxifeneGeneMutationCapecitabineACChemotherapyBevacizumabECOGScoreChemotherapyAntibodyTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GailModelCo-survivorGermlineMutationSERMMetastasisFISHRadiotherapyPalbociclibPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearKi-67RateOligometastasesCheckpointInhibitorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBOCAEstrogenChemopreventionPagetDiseaseMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltLapatinibTriplePositiveBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyEGFR(epidermalgrowth factorreceptor)BiopsyPARPInhibitorsAbsoluteRiskPrecisionMedicineBreastCancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AxillarySamplingDoxorubicinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55HerceptinMRIGuaranteedRenewableInsuranceCyclophosphamideBI-RADSmTORInhibitorsIntraductalPapillomaAdvocacyNodePositiveBilateralProphylacticMastectomyPhysicalactivity mayreduce therisk of breastcancersRADER+LumpectomyHormoneReplacementTherapyAdenocarcinomaAyurvedaPI3KinaseInhibitorsCytostaticAromataseInhibitorsNeoplasmImmunotherapyGeneticPredispositionMultifocalTumorsRelapseInvasiveBreastCancerTyrosine-KinaseInhibitorCAMMegestrolAcetateOvarianSuppressionAntiemeticPalpationApoptosisPathologicResponseMorpheaAnastrozoleSelf-examinationLumpHormoneReceptorStatusFamilyHistoryFibroadenomaTumorGradeAngiogenesisKappaEpsilonMastectomyTripleNegativeBreastCancerEstradiolGenomicTestingCMFChemotherapy1 in 8womenBreastTomosynthesisLymphoscintigraphyMultimodalityTherapyAfrican-Americanwomen have a lowerchance of breastcancer overall, butthey are 40% morelikely to die frombreast cancer thanwhite womenCystLCISMethotrexatePaclitaxelCDK4/6InhibitorsIn-situCarcinomaBRCAGene5-FluorouracilCalcificationsNodeNegativeStagingDefinitiveSurgeryDimplingExcisionalBiopsyBrachytherapyFlowCytometryDown-StagingDoseDenseTherapyCytotoxicNeoadjuvantTherapyProgestinDocetaxelCachexiaHER-2ER-LymphNodeStatusGeneticCounselingAdjuvantTherapyMastodyniaTamoxifenAlopeciaRaloxifeneGeneMutationCapecitabineACChemotherapyBevacizumabECOGScoreChemotherapyAntibodyTherapyFor every 1,000screeningmammogramsperformed, aboutfive breast cancersare detected.GailModelCo-survivorGermlineMutationSERMMetastasisFISHRadiotherapyPalbociclibPhyllodesTumorEstimated 2,150 menwill be diagnosedwith breast cancerand approximately410 will die each yearKi-67RateOligometastasesCheckpointInhibitorAlcohol intakeof more thantwo drinks perday is a riskfactor for breastcancerBOCAEstrogenChemopreventionPagetDiseaseMammography is alow-dose X-rayexamination thatcan detect breastcancer two yearsbefore it is largeenough to be feltLapatinibTriplePositiveBreastCancerWomen ages40+ shouldhave a clinicalbreast examat least yearlyEGFR(epidermalgrowth factorreceptor)BiopsyPARPInhibitorsAbsoluteRiskPrecisionMedicineBreastCancerWomen ages20-39 yoshould have aclinical breastexam at leastevery 3 years.AxillarySamplingDoxorubicinBreast cancer isthe leading causeof death in womenbetween the agesof 40 and 55HerceptinMRIGuaranteedRenewableInsuranceCyclophosphamideBI-RADSmTORInhibitorsIntraductalPapillomaAdvocacy

BOCA Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.


1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
  1. Node Positive
  2. Bilateral Prophylactic Mastectomy
  3. Physical activity may reduce the risk of breast cancers
  4. RAD
  5. ER+
  6. Lumpectomy
  7. Hormone Replacement Therapy
  8. Adenocarcinoma
  9. Ayurveda
  10. PI3 Kinase Inhibitors
  11. Cytostatic
  12. Aromatase Inhibitors
  13. Neoplasm
  14. Immunotherapy
  15. Genetic Predisposition
  16. Multifocal Tumors
  17. Relapse
  18. Invasive Breast Cancer
  19. Tyrosine-Kinase Inhibitor
  20. CAM
  21. Megestrol Acetate
  22. Ovarian Suppression
  23. Antiemetic
  24. Palpation
  25. Apoptosis
  26. Pathologic Response
  27. Morphea
  28. Anastrozole
  29. Self-examination
  30. Lump
  31. Hormone Receptor Status
  32. Family History
  33. Fibroadenoma
  34. Tumor Grade
  35. Angiogenesis
  36. Kappa Epsilon
  37. Mastectomy
  38. Triple Negative Breast Cancer
  39. Estradiol
  40. Genomic Testing
  41. CMF Chemotherapy
  42. 1 in 8 women
  43. Breast Tomosynthesis
  44. Lymphoscintigraphy
  45. Multimodality Therapy
  46. African-American women have a lower chance of breast cancer overall, but they are 40% more likely to die from breast cancer than white women
  47. Cyst
  48. LCIS
  49. Methotrexate
  50. Paclitaxel
  51. CDK4/6 Inhibitors
  52. In-situ Carcinoma
  53. BRCA Gene
  54. 5-Fluorouracil
  55. Calcifications
  56. Node Negative
  57. Staging
  58. Definitive Surgery
  59. Dimpling
  60. Excisional Biopsy
  61. Brachytherapy
  62. Flow Cytometry
  63. Down-Staging
  64. Dose Dense Therapy
  65. Cytotoxic
  66. Neoadjuvant Therapy
  67. Progestin
  68. Docetaxel
  69. Cachexia
  70. HER-2
  71. ER-
  72. Lymph Node Status
  73. Genetic Counseling
  74. Adjuvant Therapy
  75. Mastodynia
  76. Tamoxifen
  77. Alopecia
  78. Raloxifene
  79. Gene Mutation
  80. Capecitabine
  81. AC Chemotherapy
  82. Bevacizumab
  83. ECOG Score
  84. Chemotherapy
  85. Antibody Therapy
  86. For every 1,000 screening mammograms performed, about five breast cancers are detected.
  87. Gail Model
  88. Co-survivor
  89. Germline Mutation
  90. SERM
  91. Metastasis
  92. FISH
  93. Radiotherapy
  94. Palbociclib
  95. Phyllodes Tumor
  96. Estimated 2,150 men will be diagnosed with breast cancer and approximately 410 will die each year
  97. Ki-67 Rate
  98. Oligometastases
  99. Checkpoint Inhibitor
  100. Alcohol intake of more than two drinks per day is a risk factor for breast cancer
  101. BOCA
  102. Estrogen
  103. Chemoprevention
  104. Paget Disease
  105. Mammography is a low-dose X-ray examination that can detect breast cancer two years before it is large enough to be felt
  106. Lapatinib
  107. Triple Positive Breast Cancer
  108. Women ages 40+ should have a clinical breast exam at least yearly
  109. EGFR (epidermal growth factor receptor)
  110. Biopsy
  111. PARP Inhibitors
  112. Absolute Risk
  113. Precision Medicine
  114. Breast Cancer
  115. Women ages 20-39 yo should have a clinical breast exam at least every 3 years.
  116. Axillary Sampling
  117. Doxorubicin
  118. Breast cancer is the leading cause of death in women between the ages of 40 and 55
  119. Herceptin
  120. MRI
  121. Guaranteed Renewable Insurance
  122. Cyclophosphamide
  123. BI-RADS
  124. mTOR Inhibitors
  125. Intraductal Papilloma
  126. Advocacy